Drug
D0101 | Pramocaine
D
C
D04AB07 Pramocaine
[D04AB] Anesthetics for topical use
[D04A] ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
[D04] ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
[D] Dermatological drugs
C05AD07 Pramocaine
[C05AD] Local anesthetics
[C05A] AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
[C05] VASOPROTECTIVES
[C] Cardiovascular system
| Organism | Test type | Route | Dose (normalized dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | subcutaneous | 900mg/kg (900mg/kg) | Anesthesia and Analgesia Vol. 38, Pg. 265, 1959. | |
| mouse | LD50 | intraperitoneal | 300mg/kg (300mg/kg) | Anesthesia and Analgesia Vol. 38, Pg. 265, 1959. | |
| mouse | LD50 | intravenous | 79mg/kg (79mg/kg) | European Journal of Medicinal Chemistry--Chimie Therapeutique. Vol. 10, Pg. 291, 1975. | |
| .gamma.-Morpholinopropyl 4-n-butoxyphenyl ether | 068X84E056 | 140-65-8 |
| 4-(3-(4-butoxyphenoxy)propyl)morpholine | 4-(3-(p-Butoxyphenoxy)propyl)morpholine | 4-27-00-00127 (Beilstein Handbook Reference) |
| 4-[3-(4-Butoxyphenoxy)propyl]morpholine | 4-[3-(4-Butoxyphenoxy)propyl]morpholine # | AB00053605 |
| AB00053605_13 | AB00053605_14 | BDBM50225493 |
| BPBio1_001025 | BRD-K46523383-003-04-7 | BRN 0239059 |
| BSPBio_000931 | C07892 | CAS-637-58-1 |
| CHEBI:8357 | CHEMBL1198 | CTK6E3413 |
| D08407 | DB09345 | DQKXQSGTHWVTAD-UHFFFAOYSA-N |
| DTXSID8040692 | DivK1c_000882 | EINECS 205-425-7 |
| IDI1_000882 | KBio1_000882 | KBio2_001860 |
| KBio2_004428 | KBio2_006996 | KBio3_001930 |
| KBioGR_001547 | KBioSS_001860 | LS-92486 |
| MCULE-5337294231 | Morpholine, 4-(3-(p-butoxyphenoxy)propyl)- | Morpholine, 4-[3-(4-butoxyphenoxy)propyl]- |
| NCGC00016529-01 | NCGC00016529-02 | NCGC00016529-03 |
| NCGC00016529-04 | NINDS_000882 | PX9 |
| Pramocaina | Pramocaina [INN-Spanish] | Pramocaine |
| Pramocaine (INN) | Pramocaine [INN:BAN] | Pramocainum [INN-Latin] |
| Prestwick0_000716 | Prestwick1_000716 | Prestwick2_000716 |
| Prestwick3_000716 | Proxazocain | Q1240076 |
| SBI-0051653.P002 | SCHEMBL26020 | SPBio_000099 |
| SPBio_002852 | Spectrum2_000030 | Spectrum3_000925 |
| Spectrum4_001024 | Spectrum5_001511 | Spectrum_001380 |
| Tronopthane | Tronothane | UNII-068X84E056 |
| ZINC19594594 | gamma-Morpholinopropyl 4-n-butoxyphenyl ether | p-Butoxyphenyl .gamma.-morpholinopropyl ether |
| p-Butoxyphenyl gamma-morpholinopropyl ether | pramocainum | pramoxine |
| DrugBank Name | Pramocaine |
| DrugBank | DB09345 |
| CAS Number | 140-65-8, 637-58-1 |
| PubChem Compound | 4886 |
| KEGG Compound ID | C07892 |
| KEGG Drug | D08407 |
| PubChem.Substance | 310265219 |
| ChEBI | 8357 |
| ChemSpider | 4717 |
| BindingDB | 50225493.0 |
| Wikipedia | Pramocaine |
| HET | PX9 |
| DPD | 6343 |
1. Chan et al. (2005)